VCR–prednisone–L-asparaginase regimens
E1312978
UNEXPLORED
VCR–prednisone–L-asparaginase regimens are combination chemotherapy protocols commonly used in the treatment of acute lymphoblastic leukemia, particularly in pediatric patients.
All labels observed (1)
| Label | Occurrences |
|---|---|
| VCR–prednisone–L-asparaginase regimens canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T18213154 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: VCR–prednisone–L-asparaginase regimens Context triple: [vincristine, usedInRegimen, VCR–prednisone–L-asparaginase regimens]
-
A.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
B.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
C.
vincristine
Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
-
D.
Bicutan
Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
-
E.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: VCR–prednisone–L-asparaginase regimens Target entity description: VCR–prednisone–L-asparaginase regimens are combination chemotherapy protocols commonly used in the treatment of acute lymphoblastic leukemia, particularly in pediatric patients.
-
A.
BEACOPP regimen
The BEACOPP regimen is an intensive multi-drug chemotherapy protocol used primarily for advanced-stage Hodgkin lymphoma.
-
B.
R-CHOP
R-CHOP is a standard chemotherapy regimen combining rituximab with multiple cytotoxic drugs, commonly used to treat non-Hodgkin lymphoma.
-
C.
vincristine
Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
-
D.
Bicutan
Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
-
E.
ABVD regimen
The ABVD regimen is a standard chemotherapy combination used as first-line treatment for classical Hodgkin lymphoma.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.